Establishment Labs stock reaffirmed Buy at Canaccord on minimally invasive portfolio
PositiveFinancial Markets

Establishment Labs has received a positive endorsement from Canaccord, which reaffirmed its 'Buy' rating on the company's stock. This is significant as it highlights the growing confidence in Establishment Labs' minimally invasive portfolio, suggesting that investors see strong potential for growth and innovation in this area. Such endorsements can boost investor sentiment and potentially lead to increased stock value.
— Curated by the World Pulse Now AI Editorial System